Literature DB >> 2232125

[Diuretic effects of aminophylline in patients after cardiac surgery].

T Noguchi1, Y Hayano, H Iwasaka, K Setoguchi, S Oda, K Taniguchi, N Honda, Y Mori, T Hadama.   

Abstract

Diuretic effects of aminophylline in patients after cardiac surgery were studied by using the local renal thermodilution catheter (Goodman Co. Ltd.). The subjects were 11 patients who underwent cardiac surgery in our hospital. All patients had shown almost normal renal and endocrine function. On the day of operation, we indwelld renal thermodilution catheter into the left renal vein under fluoroscopy. After operation, when the urinary volume decreased below 1 ml.kg-1.hr-1, we administered aminophylline at a rate of 2 ml.kg-1.hr-1. We measured HR, BP, CO, PAP, CVP, renal blood flow, urinary volume, urinary electrolytes, plasma renin activity, angiotensin II, aldosteron, ADH and alpha hANP just before and after infusion of aminophylline. The urine volume, renal blood flow and renal blood flow distribution rate showed significant increases of about 70%, 40% and 35% respectively. But hemodynamic parameters including HR, mean BP and CO increased for 5%, 10% and 8% respectively after administration of aminophylline. In the endocrine system, only angiotensin II increased significantly but aminophylline did not cause any change in endocrine system. The results suggest that diuretic effect of aminophylline is mainly achieved by increasing renal blood flow.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2232125

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

Review 1.  Additive diuretic response of concurrent aminophylline and furosemide in children: a case series and a brief literature review.

Authors:  Paulo Sérgio Lucas da Silva; Vânia Euzébio de Aguiar; Marcelo Cunio Machado Fonseca
Journal:  J Anesth       Date:  2011-10-18       Impact factor: 2.078

2.  Aminophylline as an adjunct diuretic for neonates--a case series.

Authors:  Geraldine Yin Taeng Ng; Emma Harriet Baker; Katharine Florence Mary Farrer
Journal:  Pediatr Nephrol       Date:  2004-12-04       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.